InVitae (NVTA) to Appeal Trial Verdict Against Natera (NTRA)

Go back to InVitae (NVTA) to Appeal Trial Verdict Against Natera (NTRA)

Invitae to Appeal Trial Verdict

May 15, 2023 4:07 PM EDT

SAN FRANCISCO, May 15, 2023 /PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced that it intends to appeal the verdict delivered by a jury... More